Treatment of Primary Glomerulonephritis (Oxford Clinical Nephrology Series) (3RD)

個数:
電子版価格
¥13,382
  • 電子版あり

Treatment of Primary Glomerulonephritis (Oxford Clinical Nephrology Series) (3RD)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 640 p.
  • 言語 ENG
  • 商品コード 9780198784081
  • DDC分類 616.612

Full Description

Primary glomerulonephritis is one of the most frequent renal diseases, and a main cause of end-stage kidney disease. Glomerulonephritis has multiple subtypes, each with different physiopathologies, clinical presentations, and management requirements, which makes treatment difficult. As a complex set of diseases, the choice of symptomatic and specific treatment is critical to ameliorating the relentless course of glomerulonephritis.

Focusing on all aspects of primary glomerulonephritis, from their epidemiologies and classification, to their pathogenesis and treatment, this third edition of Treatment of Primary Glomerulonephritis has been fully updated to include the latest research and evidence-based practice. With a strong emphasis on drugs used for both symptomatic and specific treatments, mechanisms of action, effectiveness, and potential toxicity are considered for therapeutic strategies in the different subtypes of primary glomerulonephritis.

Each chapter follows a clear and logical format, allowing easy access to key information. Featuring over 20 full-colour histological images of different diseases to aid diagnosis, and with commentary from internationally recognised experts in the field, this new edition is an essential resource for all practising or academic clinical nephrologists.

Contents

1: Claudio Ponticelli and Richard Glassock: A definition, modern classification, and global epidemiology of primary glomerulonephritis
2: Richard Glassock: Symptomatic therapy
3: Claudio Ponticelli and Richard Glassock: The pharmacology of old and new agents for specific therapy of primary glomerular diseases
4: Claudio Ponticelli, Richard Glassock, and Rosanna Coppo: Minimal change disease
5: Claudio Ponticelli, Richard Glassock, and Francesco Scolari: Focal and segmental glomerular sclerosis
6: Claudio Ponticelli, Richard Glassock, and Patrizia Passerini: Membranous nephropathy
7: Richard Glassock, Claudio Ponticelli, and Kar Neng Lai: Immunoglobulin A nephropathy
8: Richard Glassock, Lee Hebert, Gabriella Moroni, and Claudio Ponticelli: Infection-related and renal-limited glomerulonephritis
9: Richard Glassock and Fernando C. Fervenza: C3 Glomerulopathies and 'idiopathic' immune complex membranoproliferative glomerulonephritis
10: Richard Glassock and Patrick Nachman: Renal-limited vasculitis
11: Claudio Ponticelli and Gabriella Moroni: Other primary glomerular diseases